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ABSTRACT: 20 
 21 
Background: Plasmodium falciparum is transmitted from humans to Anopheles mosquito 22 
vectors via the sexual erythrocytic forms termed gametocytes. Erythrocyte filtration through 23 
microsphere layers (microsphiltration) had shown that circulating gametocytes were 24 
deformable. Compounds reducing gametocyte deformability would induce their splenic 25 
clearance, thus remove them from the blood circulation and block malaria transmission.  26 
 27 
Methods: The hand-made, single-sample prototype for microsphiltration was miniaturized to 28 
a 96-well microtitre plate format, and gametocyte retention in the microsphere filters 29 
quantified by high-content imaging. The stiffening activity of 40 pharmacological compounds 30 
was assessed in microtitre plates, using a small molecule (calyculin) as a positive control. The 31 
stiffening activity of calyculin was assessed in spleen-mimetic microfluidic chips and in 32 
macrophage-depleted mice. 33 
 34 
Results: Marked mechanical retention (80-90%) of mature gametocytes was obtained in 35 
microplates following exposure to calyculin at concentrations with no effect on parasite 36 
viability. Of the 40 compounds tested, including 20 anti-malarials, only 5 endoperoxides 37 
significantly increased gametocyte retention (1.5–2.5 fold; 24 hour-exposure at 1 µM). 38 
Mature gametocytes exposed to calyculin accumulated in microfluidic chips, and were cleared 39 
from the circulation of macrophage-depleted mice as rapidly as heat-stiffened erythrocytes, 40 
thus confirming results obtained using the microsphiltration assay.  41 
 42 
Conclusions: An automated miniaturized approach to select compounds for their gametocyte-43 
stiffening effect has been established. Stiffening induces gametocyte clearance both in vitro 44 
and in vivo. Based on physiologically validated tools, this screening cascade can identify 45 
novel compounds and uncover new targets to block malaria transmission. Innovative 46 
applications in hematology are also envisioned. 47 
 48 
Key words: malaria; Plasmodium falciparum, transmission, deformability, spleen, clearance, 49 
screening, microspheres, gametocytes, high content imaging. 50 
 51 
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INTRODUCTION:  52 
Every 2-3 hours, human red blood cells (RBC) enter the open and slow microcirculation of 53 
the spleen where they cross 2 µm-wide inter-endothelial slits before returning to the general 54 
circulation [1]. In several inherited or acquired diseases, RBC are unable to deform 55 
sufficiently to overcome this mechanical challenge [2]. Their splenic retention subsequently 56 
induces anemia and splenomegaly [3]. Plasmodium falciparum (Pf)-malaria is the most 57 
frequently acquired disease where RBC deformability is affected [4]. Intra-erythrocytic 58 
asexual parasitic stages develop during a 2-day replication cycle, where rings evolve to multi-59 
nucleated schizonts that rupture the host RBC, thus releasing daughter merozoites which re-60 
invade new RBC [4]. Asexual maturation results in extensive RBC remodeling [5] through 61 
parasite growth and exported proteins which restructure the RBC and trigger stiffening [6]. 62 
Rings are modestly deformable, a proportion of them circulate [7]. Mature-asexual stages are 63 
rigid and sequester in micro-vessels where they are protected from splenic mechanical 64 
clearance [8]. Pf transmission from humans to mosquitoes relies on the conversion of a small 65 
fraction of asexual parasites to sexual stages, called gametocytes [9]. P. falciparum 66 
gametocytes develop throughout a 2-week period during which immature stages are 67 
sequestered, predominantly in the extravascular compartment of the bone marrow [10, 11]. 68 
Remodeling of the erythrocyte and parasite membrane also occurs during sexual development 69 
[12, 13]. Stiff, immature gametocytes become deformable mature gametocytes that are 70 
released into the peripheral circulation [14, 15]. Circulating mature gametocytes must then 71 
repeatedly cross splenic inter-endothelial slits. Their ability to traverse these slits is essential 72 
for their persistence in circulation and availability to mosquitoes [1]. 73 
One strategy towards Pf-malaria elimination focuses on the discovery of compounds blocking 74 
gametocyte transmission from humans to mosquitoes. Several screening assays have been 75 
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reported [1, 16-24] which identified small molecules that kill gametocytes or affect their 76 
development in the mosquito. To expand the repertoire of transmission-blocking compounds 77 
and uncover new modes of action, we propose a unique screening approach to identify 78 
compounds that will stiffen mature gametocytes, thus triggering their splenic mechanical 79 
retention [25]. Once cleared from the circulation, mature gametocytes will be removed from 80 
the transmission cycle. 81 
Most existing methods to study the deformability of Pf-infected RBC [7, 26, 27] are not yet 82 
compatible with the stringent requirements for high throughput screening (HTS). A single-83 
sample microsphere filtration (microsphiltration) device to measure the ability of RBC to 84 
squeeze between calibrated microspheres, thus mimicking the spleen, has been recently 85 
developed [28]. The physiological relevance of microsphiltration was demonstrated by 86 
obtaining similar retention rates for abnormally deformable RBC in the device and in human 87 
spleens perfused ex-vivo [28]. We report here on the development and validation of a 88 
microplate version of the microsphiltration device. Microplate filtration is well adapted to 89 
screen for compounds that will stiffen mature gametocytes. Pharmacological stiffening 90 
observed in the microsphiltration assay translated into gametocyte entrapment in microfluidic 91 
chips and in their clearance from the circulation of macrophage-depleted mice. Based on these 92 
physiologically validated tools, this approach can identify novel compounds and uncover new 93 
targets to block malaria transmission.  94 
 95 
MATERIALS AND METHODS:  96 
Preparation of microsphiltering microplates 97 
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Calibrated microsphere mixtures (AMTech® 96.5% tin, 3% silver, 0.5% copper), 25-45µm 98 
and 5-15µm were resuspended at 2 and 3g/mL, respectively, in phosphate buffered saline 99 
(PBS, Sigma) supplemented with 0.5% Albumax II (Life Technologies), then allowed to 100 
settle. Fifty µL of 25-45µm microsphere solution was transferred to 96-deep well filter 101 
bottom plate (Harvard Apparatus) using a Biomek 3000 liquid handler (Beckman Coulter), 102 
then 60µL of 5-15µm microspheres were added, resulting in an ~1.15mm-thick layer.  103 
Parasite culture  104 
The Plasmodium falciparum, NF54-derived Pfs16-luciferase-GFP transgenic clone 3 [29], 105 
was cultured as described [16, 30] using RPMI 1640 with L-Glutamine and 25mM 4-(2-106 
hydroxyethyl)-1-piperazine-ethane-sulfonic acid (HEPES) supplemented with 2.5mg/ml 107 
Albumax II (Life Technologies), 5% AB+ Male Human Serum, 50µg/mL of Hypoxanthine 108 
and 2µg/ml Blasticidin (Sigma). Gametocyte growth media without blasticidin was 109 
supplemented with 0.5M N-acetyl-glucosamine (NAG) and 11mM Glucose (Sigma). Highly 110 
synchronous gametocyte cultures were induced from asexual cultures [16] within a 12 hour 111 
window at the outset of gametocytogenesis and uniformly differentiated Stage V gametocytes 112 
were harvested at day 12 or 13 post-induction for deformability experiments. For selected 113 
mouse experiments, mixtures of immature and mature gametocytes were used. 114 
Light microscopy 115 
Thin blood films were fixed in 100% methanol, stained with Giemsa (Sigma) and counted 116 
using 100X oil immersion objective and bright-field illumination. The percentage sexual or 117 
asexual stages was counted against 104 RBC. 118 
PKH26 and PKH67-labeling of normal and heated RBC 119 
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RBC were washed with PBS and heated at 50°C for 20 minutes. Heated and control RBC 120 
were labeled using PKH26 or PKH67 Fluorescent Cell Linker Kit for General Cell Membrane 121 
Labeling (Sigma Aldrich) as described [28]. PKH-labeled RBC were resuspended in assay 122 
buffer (for asexual) or PBS-Albumax II 1% and mixed 1:20 with unlabeled RBC.  123 
Flow cytometry 124 
PKH-labeled RBC were quantified with a BD Accuri C6 flow cytometer using 488nm (PKH-125 
67) and 640nm (PKH-26) laser excitation. Cells were resuspended in PBS at 106/mL and 126 
parasitemia determined from acquisition of ˃30x103 events. Data were collected and 127 
processed using the BD Accuri C6 software. 128 
Microsphiltration  129 
Following loading with stage V mature gametocyte (200µL per well at 2% hematocrit, 5% 130 
gametocytemia) or control samples, microtitre plates were vacuum aspirated using a manifold 131 
system (Beckman Coulter) coupled to an electric High Output vacuum pump (Millipore) via a 132 
10L trap. Sample aspiration (peak pressure of 7 In.Hg) was followed by a rinsing step with 133 
1.6mL of gametocyte culture medium without NAG (vacuum aspiration, peak pressure of 10 134 
In.Hg). The downstream sample of 1.8mL was retrieved and RBC populations quantified. 135 
Compound Testing 136 
Forty-compounds consisting of 20 FDA-approved drugs and 20 antimalarial agents were 137 
selected for assay validation. Two hundred µL of mature gametocyte culture at day 11 post-138 
induction, 2.5% hematocrit and ~3-5% parasitemia were dispensed into polypropylene plates 139 
containing compounds at 5µM or 0.5µM in 50µL of gametocyte growth media and final 0.4% 140 
dimethyl sulfoxide concentration (DMSO), then incubated with gas permeable sealed 141 
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membranes (Corning) for 24h in a 37°C incubator. As negative and positive control, 142 
gametocytes were exposed to 50nM Calyculin, a phosphatase inhibitor without effect on the 143 
deformability of uninfected RBC [31] or 0.4% DMSO, respectively.  144 
Opera high content imaging  145 
Following microsphiltration, 4.5µL (approximately 105 RBC) of each filtered sample and 146 
their corresponding unfiltered control diluted to a final hematocrit of 0.2% were transferred 147 
using an Agilent Bravo liquid handler to 384-well CellCarrier imaging plates (Perkin Elmer) 148 
containing 45.5µL of Cell Mask Plasma Membrane Orange® stain (Life Technology) diluted 149 
1:13,333 in PBS.   150 
Quantification of gametocytemia was determined using high content confocal imaging 151 
(Opera™, Perkin Elmer) through acquisition of 17 images per well using a 20X water 152 
immersion objective (NA 0.7) resulting in at least 104 erythrocytes per well. GFP-positive 153 
gametocytes were detected using 488nm excitation with 520/35nm emission and CellMask 154 
Orange labelled erythrocytes were detected with 560nm excitation and 600/40 emission.  155 
Data analysis 156 
Images were processed using the Opera™ Harmony® software (PerkinElmer) using image 157 
segmentation algorithms. Gametocytes were classified and counted based on elongation 158 
index, size and GFP intensity. RBC were detected using CellMask Orange staining intensity, 159 
circularity and size. Gametocytemia (up- and downstream) was defined as the total number of 160 
gametocytes detected divided by that of erythrocytes, and the corresponding retention rate 161 
was calculated as described [28]. Significance probability for compound-induced gametocyte 162 
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stiffening was calculated using non-parametric, U-statistic Mann Whitney test with two tailed 163 
P value and confidence interval of 99%. 164 
Microfluidics 165 
The microfluidic biochips were cast in polydimethylsiloxane (PDMS, Sylgard, France), a 166 
silicone elastomer produced as described [32]. Each biochip comprised 8 parallel filtering 167 
units connected to infusion tubing. Biochips were coated with PBS 1% albumin before all 168 
experiments. Cultures containing 5% mature gametocytes at 2% hematocrit were exposed to 169 
Calyculin (50 nM) or control DMSO 0.4% for 2 hours prior labeling with Hoechst or Sybr 170 
Green (Life Technologies), mixing in a 1:1 ratio and centrifugation. RBC samples were 171 
infused using a push-syringe as 100% RBC concentrate of 20µL eluted with PBS-Albumax II 172 
1% under a 200 (+/- 50) µL/hour flow rate and 150 (+/- 50) mbar pressure. Enrichment of 173 
mature gametocytes in the slits of each filtering units was quantified from fluorescent 174 
microscope images (Leica DMI3000 microscope, using Leica DFC310FX camera controlled 175 
LAS Superposition Image software, Leica Micro-système, Nanterre, France) acquired 15 176 
minutes post-infusion. Counting was performed by 3 independent unbiased evaluators. 177 
Splenic mechanical retention of gametocytes in mice 178 
All in vivo experiments were performed in accordance with the protocols of the Pasteur 179 
Institute (Paris) and the Guidelines for the Care and Use of Laboratory Animals [33]. 180 
Experiments were performed with C57BL6 adult mice (8-12 weeks) injected or not with 181 
100µL clodronate liposome (ClodronateLiposomes.com®, Netherlands) for macrophage 182 
depletion 24 and 48 hours prior to the transfusion of human cells. Mice were injected retro-183 
orbitally with 100µL human RBC suspensions at 20% hematocrit (in culture media) 184 
containing 40% of heat-stiffened RBC (HRBC) or immature (3-10 days post-induction) or 185 
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mature (12-14 days post-induction) P. falciparum gametocytes (NF54 or Pf16). For 186 
assessment of calyculin stiffening activity, mature gametocyte cultures were exposed for 2 187 
hours to either calyculin (100nM) or control DMSO (0.4%) before injection in clodronated 188 
mice. For control experiments, HRBC (50°C, 20 minutes) or control unheated RBC (nRBC) 189 
were differentially labeled with PKH-26 and PKH-67, respectively, prior to injection. Blood 190 
samples were then collected from the tail vein 1, 90 and 180 minutes post-injection. 191 
Circulating concentrations of heated and unheated human RBC were determined by flow 192 
cytometry. The concentration of mature and immature gametocytes was determined by 193 
microscopic examination of Giemsa-stained blood films. 194 
195 
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RESULTS: 196 
96-well microsphiltration mimics splenic retention of Pf infected and abnormal RBC. 197 
To improve throughput, the tip-based microsphiltration method [28] was adapted to a 96-well 198 
microplate format. Deep-well plates designed for vacuum-based filtration were prepared with 199 
two layers of microspheres, designed to replicate the filtering properties of the tip-based 200 
approach. Optimal dispensing of microspheres into the plates was standardized using an 201 
automated liquid dispenser (Fig 1-A, b). A two-step vacuum-based aspiration protocol was 202 
validated (Figure 1-B). The microsphere matrix remained wet between filtration steps, and the 203 
morphology of filtered RBC was preserved (Fig 1D).  204 
Mimicry of splenic mechanical sensing was confirmed by quantifying the retention rates of 205 
uninfected RBC and Pf asexual blood stages. As expected, weak retention (<10%) was 206 
observed for normal RBC (Figure 1-C). Heat-stiffened RBC [35] were retained by more than 207 
90%. As previously observed with the tip-based prototype, ring stage Pf-infected RBC 208 
showed moderate retention at 35.8 ± 10.7%, while mature asexual stages were retained at 81.5 209 
± 5.1% (Fig 1-C). The relatively wide distribution of retention rates for rings was related to 210 
their increasing loss in surface area to volume ratio as the parasite matures [35,36] and the 211 
distribution of ages across different experiments. These retention rates represent a dynamic 212 
range of filtering capability consistent with previously published results [28] using the single-213 
sample prototype or ex vivo human spleen perfusion [37]. These data illustrate the successful 214 
development of microplate-based microsphiltration for rapid and robust determination of 215 
spleen-like retention of RBC samples. 216 
Increased throughput and automated quantification of gametocytes  217 
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Retention rates of RBC harbouring asexual Pf stages in the microsphiltration assay were 218 
determined using Sybr green and flow cytometry analysis. Retention rates calculated either 219 
from Giemsa-stained blood films or flow cytometry showed a strong linear correlation (r2 ≥ 220 
0.9; Fig 2-A). Retention rates of gametocytes was determined using high content imaging 221 
based on RBC labelling with a fluorescent membrane stain and gametocyte GFP expression 222 
[29]. A strong linear correlation (r2 = 0.96) was obtained between manual counting using a 223 
hemocytometer and imaging-based quantification, across the full range of mature gametocyte 224 
concentrations relevant for this assay (Figure 2B).    225 
 226 
Proof of concept for pharmacological screening using microsphiltering microplates 227 
Using the microsphiltration assay, untreated or DMSO-exposed, mature gametocytes 228 
exhibited less than 50% retention (Figure 3-A). Exposure to 50nM calyculin  for 2 and 24 229 
hours resulted in a significant increase in retention to 89.85 ± 5.17% and 79.26 ± 3.21% (p < 230 
0.0001), respectively. Evaluation of calyculin gametocytocidal activity using a mitotracker-231 
based viability assay [17] showed a ˂25% inhibition at 100nM (Fig 3-A). The difference in 232 
retention rates between DMSO and calyculin-exposed gametocytes provided a screening 233 
window stable across 3 independent biological replicates, with an average Z’ score of 0.67.  234 
Forty compounds, including 20 anti-malarial agents and 20 FDA-approved drugs were tested 235 
using the assay. None of the 20 FDA-approved drugs significantly increased gametocyte 236 
retention above negative control values. Of the 20 anti-malarial agents tested with a 24-hour 237 
exposure, only 5 endoperoxide derivatives, namely artemether, dihydro-artemisimin (DHA), 238 
artesunate (ART), artemisinin and artemisone were found active at 1µM (p < 0.0001) (Fig 3-239 
B, C, D). Assessment of gametocytocidal activity for these compounds revealed killing 240 
activity at concentrations lower than those inducing mechanical retention (Supplementary Fig 241 
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S1). The microtitre plate-based microsphiltration platform thus determined the gametocyte-242 
stiffening effect of multiple compounds in parallel. 243 
Physiological relevance of the screening process 244 
To confirm that a compound identified as active in the microsphiltration assay induces the 245 
mechanical blockade of compound-exposed gametocytes in the spleen, we analyzed the fate 246 
of gametocytes treated with calyculin in vitro and in vivo.  247 
Mechanical blockade in a spleen-mimetic microfluidic chip: Mature gametocytes from 2 248 
different laboratory strains and a sample directly collected from the blood of a P. falciparum-249 
infected-patient were exposed to calyculin at 50 nM for 2 hours, then infused through 250 
microfluidic chips. This method has been shown to recapitulate the mechanical constraints 251 
imposed on RBC as they cross inter-endothelial slits in the human spleen and validated with 252 
an array of poorly deformable RBC [32]. Exposure to calyculin induced a marked enrichment 253 
to 72.40 ± 13.64% in mature gametocytes in the narrowest slits of the chips versus 27.60 ± 254 
13.64% for the DMSO-exposed gametocytes (Fig 4A) (p < 0.0001). Thus, the altered 255 
mechanical behavior of pharmacologically-stiffened mature gametocytes observed with the 256 
microsphiltration assay was confirmed using microfluidic chips as an independent measure of 257 
spleen-like retention. This provides a physiologically relevant validation of active compounds 258 
identified by microsphiltration. 259 
Clearance of pharmacologically-stiffened gametocytes from the blood of macrophage-260 
depleted mice: Gametocytes exposed to either calyculin or 0.4% DMSO were transfused into 261 
C56Bl6 mice previously treated with clodronate liposomes to deplete endogenous 262 
macrophages and allow normal human RBC to circulate for several hours (Fig 4B, C and D). 263 
As expected, when untreated mice were transfused with human RBC a complete clearance 264 
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was observed in less than 90 minutes. By contrast, 73.19 ± 26.87% and 58.53 ± 12.97% of 265 
human RBC (p = 0.0006) were still in circulation at 90 and 180 minutes, respectively, after 266 
transfusion into macrophage-depleted mice. In these macrophage-depleted mice, only 35.63 ± 267 
24.42% and 22.98 ± 6.94% of stiff, heat treated RBC remained in circulation after 90 and 180 268 
minutes, corresponding to  ˃75% clearance, arguably by a macrophage-independent, 269 
mechanical process (Fig 4B). When gametocyte circulation kinetics were examined, we found 270 
that 81.21% of immature compared to 15.35% of mature gametocytes were cleared after 90 271 
minutes (p = 0,0005). This result is consistent with previous studies which demonstrated a 272 
marked difference in the stiffness of immature and mature stages using biorheological 273 
methods [14, 15] (Fig 4C). Finally, mature gametocytes exposed to calyculin for 2 hours had 274 
a clearance rate of 77.52%, whereas exposure to 0.4% DMSO resulted in only 34.83% 275 
retention after 180 minutes (p = 0.0286). Interestingly, these clearance rate kinetics were 276 
almost identical with those of nRBC (26.97%) and HRBC (77.01%). Hence, a compound 277 
active in the microsphiltration assay induces the splenic mechanical retention of gametocytes 278 
in vivo (Fig 4D). 279 
280 
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Discussion: 281 
Using a miniaturized microsphiltration assay designed to mimic the mechanical sensing of 282 
RBC by the spleen, we have demonstrated that a small molecule can significantly impair the 283 
ability of mature P. falciparum gametocytes to cross spleen-like slits, independently from 284 
gametocyte killing.  This finding was confirmed in vitro using biomimetic microfluidic chips, 285 
and in vivo using a macrophage-depleted mouse model. Collectively, these results establish an 286 
original screening and post-screening cascade to select compounds that induce the mechanical 287 
retention of mature gametocytes in the human spleen, thus eliminating them from the malaria 288 
transmission cycle. Once retained in the spleen, the fate of a RBC is macrophage-mediated 289 
phagocytosis and destruction.  Mechanical retention of RBC is effective in malaria patients 290 
[1] [34]. Therefore, compounds which induce retention and clearance of mature gametocytes 291 
in the spleen represent solid candidates as transmission-blocking agents.   292 
To find transmission-blocking agents through an original, biomechanical approach we 293 
optimized the manual microsphiltration prototype to a miniaturized automated format. This 294 
effectively streamlined the processing of 96 samples in a simultaneous fashion with the 295 
potential to screen up to 5,000-10,000 compounds in single point, over a 1 to 2-month period. 296 
We have also developed specific tools to validate this approach. Lavazec and colleagues 297 
recently identified compounds interfering with a signalling pathway that regulates 298 
gametocyte-infected RBC deformability. The identification of calyculin [31] has provided the 299 
much needed tool for validation of the screening approach reported here. We have 300 
demonstrated that calyculin stiffens gametocytes at concentrations lower than those affecting 301 
gametocyte viability (Fig 3). This stiffening activity was further confirmed using biomimetic 302 
microchips with narrow 2 micron-wide slits [32] in which gametocytes exposed to calyculin 303 
accumulated after a few minutes of infusion (Fig 4A). To validate the effect of hits in vivo, 304 
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we developed a new transfusion approach in mice. The mouse and human spleens retain 305 
autologous spherocytic RBC at a similar pace [38, 34] and the minimal surface area loss 306 
triggering biomechanical retention is also similar in both species, namely >18% in human 307 
spleens [35] and >20% in mice [38]. Macrophage depletion was used to allow human RBC to 308 
remain in the peripheral circulation of C57BL6 mice. As expected, those human RBC were 309 
rapidly cleared from the circulation of macrophage-intact controls (Fig 4B), while the 310 
majority of them were still in the peripheral blood of macrophage-depleted mice 3 hours after 311 
xenotransfusion. In this model, a minority of mature gametocytes and a majority of immature 312 
gametocytes were cleared, consistent with previous observations in vitro [14]. Similarly, only 313 
a minority of mature gametocytes exposed to DMSO and a majority of those exposed to 314 
calyculin were cleared. This strongly suggests that calyculin induces the clearance of mature 315 
gametocytes in vivo by inducing their mechanical retention in the spleen [33, 40].  316 
In the first set of compounds tested, most were inactive and induced retention rates very 317 
similar to those observed with the solvent control (DMSO) (Fig 3).  Five endoperoxides were 318 
identified as actives, however, as opposed to calyculin, induced retention only at 319 
concentrations higher than those affecting viability (Fig 3 & Fig S1). Mechanical retention 320 
was thus more likely a consequence of gametocyte killing rather than a new mode of action of 321 
endoperoxides on gametocyte carriage. Interestingly, artemether affected the viability of 322 
mature gametocytes at lower concentrations than dihydroartemisinin. This is consistent with 323 
the greater effect artemether-lumefantrine has on gametocyte carriage and transmission to 324 
Anopheles compared to DHA-piperaquine [41].  325 
The ideal compound selected by our screening/post-screening cascade would induce a potent, 326 
irreversible increase in the retention of mature gametocytes and have a long half-life. 327 
Duration of gametocyte carriage is reduced from 7 to 2 weeks in malaria patients treated with 328 
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ACTs [42, 43]. A mean duration of activity of two weeks would thus cover the gametocyte 329 
circulation period in ACT-treated patients. What is the minimal activity that would translate 330 
into public health benefit? Modeling indicates that the prediction is complex, due to a possibly 331 
non-linear relationship between gametocytemia and transmission to Anopheles [44] and a 332 
wide diversity of epidemiological situations. While moderately active compounds (eg, 80% 333 
retention) would impact transmission from subjects carrying ˃250-300 gametocytes/μl, only 334 
solidly active compounds (> 98% retention) would have an impact in subjects with ˂20 335 
gametocytes/μl. Whatever the anti-gametocyte approach used, reducing transmission from 336 
subjects with intermediate gametocytemia (20-200 gametocytes/μl) will require very potent 337 
activity. If modeling accurately reflects reality, combining a gametocyte-killing agent from 338 
ongoing screening activities [16-24] with a gametocyte-stiffening agent from our 339 
biomechanical approach may increase the likelihood for transmission-blocking success.  340 
Following assay optimization, microplate-based microsphiltration proved robust and flexible. 341 
The results were reproducible across multiple microplate formats, utilizing various automated 342 
dispensers, different microsphere sources and microsphiltration media. Optimization by 343 
analyzing male/female and reversible/irreversible effects is envisioned. We have developed a 344 
storage process that preserves the integrity of the microsphere layer and assay performance 345 
for 3 months thereby enabling transport and deferred use at distant laboratories (not shown). 346 
Potential applications include HTS to discover compounds modulating the biomechanical 347 
properties of RBC in conditions such as diabetes [45], sepsis and inflammatory diseases [46], 348 
inherited RBC disorders [47], or transfusion [48]. The assay may also provide a quality 349 
control test for RBC concentrates, as poorly deformable subpopulations of RBC tend to 350 
accumulate upon storage [28, 49]. 351 
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FIGURE LEGENDS 532 
Figure 1: From the hand-made, single-sample prototype to a high throughput 533 
microphiltration assay using microplates.  (A) In the prototype, 5 – 25 µm microspheres 534 
were directly deposited by hand above the anti-aerosol filter of a tip. In the microplate assay, 535 
25 to 45µm-diameter microspheres [2] were poured using automated dispenser into 96-well 536 
filter mesh plates to support a 1.15 mm-thick layer of 5-15µm microspheres [1] forming the 537 
matrix mimicking the geometry of splenic slits [28]. (B) The driving force for 538 
microsphiltration in the Tip format was applied using syringes connected to hermetic tubing. 539 
The RBC sample was gently pushed by hand into the filter [1]. An electric pump then flushed 540 
the rinsing medium across the filter [2]. In the microplate format, microsphiltration was 541 
operated by vacuum aspiration in 2 steps; the sample was aspirated into the microsphere layer 542 
[1], and then rinsed using microsphiltration medium [2]. The use of deep-well microplates 543 
allowed rinsing to be performed in a single step from the filtering to the receiver plate. (C) 544 
The microplate format displayed physiologically relevant retention (mean retention ± SD) of 545 
an array of RBC subpopulations, including normal (nRBC), heat-stiffened RBC (HRBC), or 546 
RBC infected with P. falciparum asexual stages (Rings, Troph=Trophozoits, 547 
Schiz=Schizonts). (D) Microplate-based microsphiltration is an open system preserving the 548 
morphology of infected and uninfected RBC (Giemsa-stained smears up- and down-stream 549 
from filters).  550 
 Figure 2: Accurate, automated quantification of asexual and sexual stages up- and 551 
down-stream from filters. A linear correlation was observed between parasitemia (A) and 552 
retention rates (B) determined either by Flow cytometry or by reference method (conventional 553 
counting on Giemsa-stained smears under the microscope). Parasite populations were filtered 554 
at different stages of asexual maturation under different experimental conditions to cover a 555 
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broad range of retention rates. Pooled results from 6 independent experiments are shown. (C) 556 
A linear correlation was observed between gametocyte concentrations determined either by 557 
Opera high content imaging or by reference method (hemocytometer) (n=3). (D) Example 558 
image taken using Opera confocal microscope of GFP-expressing Pf16 stage V gametocytes 559 
which were quantified and analyzed automatically. 560 
Figure 3: Robust determination of retention rates after exposure of gametocytes to 40 561 
different compounds as a proof-of-concept for application for screening. (A-i/) Single-562 
well retention rates (mean values ± SD) of mature stage V gametocytes were determined by 563 
microplate-based microsphiltration after a 2- or 24-hour exposure to DMSO at 0.4% or 564 
calyculin (50 nM). Compared to unexposed controls (GAM V), 0.4% DMSO did not alter 565 
gametocyte retention rates (GAM V-DMSO, 2 & 24H) while calyculin significantly increased 566 
their mechanical retention (GAM calyculin, 2 & 24H). (A-ii/) The same concentration of 567 
calyculin (50 nM) did not significantly affect the viability of mature gametocytes at 24H. (B) 568 
Retention rates (mean values ± SEM) of stage V gametocytes measured after a 24H exposure 569 
with 40 pharmacological compounds at 0.1 and 1 µM (n=3). Only artemether, dihydro-570 
artemisimin (DHA), artesunate (ART) artemisinin and artemisone (all endoperoxides) 571 
significantly decreased gametocyte ability to cross microsphere filters at 1µM (C, D).  572 
 Figure 4: Mechanical clearance of compound-exposed mature gametocytes in vitro and 573 
in vivo to validate screening. A) Mechanical retention (mean values ± SD) of mature 574 
gametocytes in the filtering units of spleen-like biomimetic microchips as quantified by 575 
fluorescence microscopy. Calyculin-stiffened gametocytes were significantly enriched 576 
compared to controls. B) C57BL6 mice were treated (Full line) or not (Doted line) with 577 
clodronate liposome for macrophage depletion prior to the transfusion of human RBC. Heat-578 
stiffened human RBC (HRBC, Purple line) or control unheated RBC (nRBC, Red line) were 579 
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injected retro-orbitally after differential labeling with PKH-26 and PKH-67), for subsequent 580 
quantification using flow cytometry. Blood samples were collected at the tail vein 1, 90 and 581 
180 minutes post-injection (4 independent experiments for a total of 15 mice). C) 582 
Macrophage-depleted C57BL6 mice were transfused with human RBC infected with either 583 
immature (Dotted line, [stage I-IV]) or mature (Full line, [stage V]) gametocytes. The 584 
concentration of circulating gametocytes was determined on Giemsa-stained smears showing 585 
the persistence in circulation of a majority of RBC infected with mature gametocytes and the 586 
clearance of a majority of RBC infected with immature gametocytes (4 independent 587 
experiments for a total of 12 mice). D) Macrophage-depleted C57BL6 mice were transfused 588 
with human RBC infected with mature P. falciparum gametocytes, exposed just before 589 
transfusion either to calyculin at 100 nM or control DMSO 0.4% during 2 hours (2 590 
independent experiments for a total of 8 mice). A majority of mature gametocytes exposed to 591 
calyculin (Green line) were cleared while a majority of mature gametocytes exposed to the 592 
solvent (Blue line) stayed in circulation (p = 0.0286). Red dotted line: nRBC and Purple 593 
dotted line: HRBC. Results from these mice experiments are expressed as mean values ± 594 
SEM.  595 
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Figure 1: From the hand-made, single-sample prototype to a high throughput microphiltration 
assay using microplates.  (A) In the prototype, 5 – 25 µm microspheres were directly deposited by 
hand above the anti-aerosol filter of a tip. In the microplate assay, 25 to 45µm-diameter microspheres 
[2] were poured using automated dispenser into 96-well filter mesh plates to support a 1.15 mm-thick 
layer of 5-15µm microspheres [1] forming the matrix mimicking the geometry of splenic slits [28]. 
(B) The driving force for microsphiltration in the Tip format was applied using syringes connected to 
hermetic tubing. The RBC sample was gently pushed by hand into the filter [1]. An electric pump 
then flushed the rinsing medium across the filter [2]. In the microplate format, microsphiltration was 
operated by vacuum aspiration in 2 steps; the sample was aspirated into the microsphere layer [1], 
and then rinsed using microsphiltration medium [2]. The use of deep-well microplates allowed 
rinsing to be performed in a single step from the filtering to the receiver plate. (C) The microplate 
format displayed physiologically relevant retention (mean retention ± SD) of an array of RBC 
subpopulations, including normal (nRBC), heat-stiffened RBC (HRBC), or RBC infected with P. 
falciparum asexual stages (Rings, Troph=Trophozoits, Schiz=Schizonts). (D) Microplate-based 
microsphiltration is an open system preserving the morphology of infected and uninfected RBC 
(Giemsa-stained smears up- and down-stream from filters). 
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Figure 2: Accurate, automated quantification of asexual and sexual stages up- and down-stream 
from filters. A linear correlation was observed between parasitemia (A) and retention rates (B) 
determined either by Flow cytometry or by reference method (conventional counting on Giemsa-
stained smears under the microscope). Parasite populations were filtered at different stages of asexual 
maturation under different experimental conditions to cover a broad range of retention rates. Pooled 
results from 6 independent experiments are shown. (C) A linear correlation was observed between 
gametocyte concentrations determined either by Opera high content imaging or by reference method 
(hemocytometer) (n=3). (D) Example image taken using Opera confocal microscope of GFP-
expressing Pf16 stage V gametocytes which were quantified and analyzed automatically. 
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Figure 3: Robust determination of retention rates after exposure of gametocytes to 40 different 
compounds as a proof-of-concept for application for screening. (A-i/) Single-well retention rates 
(mean values ± SD) of mature stage V gametocytes were determined by microplate-based 
microsphiltration after a 2- or 24-hour exposure to DMSO at 0.4% or calyculin (50 nM). Compared 
to unexposed controls (GAM V), 0.4% DMSO did not alter gametocyte retention rates (GAM V-
DMSO, 2 & 24H) while calyculin significantly increased their mechanical retention (GAM calyculin, 
2 & 24H). (A-ii/) The same concentration of calyculin (50 nM) did not significantly affect the 
viability of mature gametocytes at 24H. (B) Retention rates (mean values ± SEM) of stage V 
gametocytes measured after a 24H exposure with 40 pharmacological compounds at 0.1 and 1 µM 
(n=3). Only artemether, dihydro-artemisimin (DHA), artesunate (ART) artemisinin and artemisone 
(all endoperoxides) significantly decreased gametocyte ability to cross microsphere filters at 1µM (C, 
D). 
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Figure 4: Mechanical clearance of compound-exposed mature gametocytes in vitro and in vivo 
to validate screening. A) Mechanical retention (mean values ± SD) of mature gametocytes in the 
filtering units of spleen-like biomimetic microchips as quantified by fluorescence microscopy. 
Calyculin-stiffened gametocytes were significantly enriched compared to controls. B) C57BL6 mice 
were treated (Full line) or not (Doted line) with clodronate liposome for macrophage depletion prior 
to the transfusion of human RBC. Heat-stiffened human RBC (HRBC, Purple line)  or control 
unheated RBC (nRBC, Red line) were injected retro-orbitally after differential labeling with PKH-26 
and PKH-67), for subsequent quantification using flow cytometry. Blood samples were collected at 
the tail vein 1, 90 and 180 minutes post-injection (4 independent experiments for a total of 15 mice). 
C) Macrophage-depleted C57BL6 mice were transfused with human RBC infected with either 
immature (Dotted line, [stage I-IV]) or mature (Full line, [stage V]) gametocytes. The concentration 
of circulating gametocytes was determined on Giemsa-stained smears showing the persistence in 
circulation of a majority of RBC infected with mature gametocytes and the clearance of a majority of 
RBC infected with immature gametocytes (4 independent experiments for a total of 12 mice). D) 
Macrophage-depleted C57BL6 mice were transfused with human RBC infected with mature P. 
falciparum gametocytes, exposed just before transfusion either to calyculin at 100 nM or control 
DMSO 0.4% during 2 hours (2 independent experiments for a total of 8 mice). A majority of mature 
gametocytes exposed to calyculin (Green line) were cleared while a majority of mature gametocytes 
exposed to the solvent (Blue line) stayed in circulation (p = 0.0286). Red dotted line: nRBC and 
Purple dotted line: HRBC. Results from these mice experiments are expressed as mean values ± 
SEM. 
